Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

Barry Hendin,1 Robert T Naismith,2 Sibyl E Wray,3 Deren Huang,4 Qunming Dong,5 Terrie Livingston,6 Daniel L Jones,6 Crystal Watson,7 Mehul Jhaveri6 1Phoenix Neurological Associates, Phoenix, AZ, USA; 2Department of Neurology, Washington University School of Medicine, St Louis, MO, USA; 3Hope Neurol...

Full description

Bibliographic Details
Main Authors: Hendin B, Naismith RT, Wray SE, Huang D, Dong Q, Livingston T, Jones DL, Watson C, Jhaveri M
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Patient Preference and Adherence
Subjects:
interferon beta-1a
interferon beta-1b
peginterferon beta-1a
relapsing multiple sclerosis
treatment satisfaction
Treatment Satisfaction Questionnaire for Medication (TSQM)
Online Access:https://www.dovepress.com/treatment-satisfaction-significantly-improves-in-patients-with-multipl-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/treatment-satisfaction-significantly-improves-in-patients-with-multipl-peer-reviewed-article-PPA

Similar Items